We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current RDTCF market cap is 27.54M. The company's latest EPS is CAD -0.0346 and P/E is -7.23.
| Year End February 27 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Total Revenue | 0 | 101k | 263k | 1.75M | 718k |
| Operating Income | -11.48M | -7.18M | -1.82M | -3.73M | -3.09M |
| Net Income | -11.4M | -7.96M | -2.3M | -8.49M | -3.81M |
| Year End February 27 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Total Assets | 5.78M | 4.29M | 3.83M | 3.07M | 2.25M |
| Total Liabilities | 1.96M | 4.44M | 5.41M | 2.82M | 4.92M |
| Total Equity | 3.83M | -148k | -1.58M | 252k | -2.67M |
| Year End February 27 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Operating | -2.13M | -3.03M | -1.62M | -3M | -864k |
| Investing | -3.89M | 530k | -9k | 1.86M | N/A |
| Financing | 6.97M | 1.24M | 1.65M | 1.13M | 857k |
| Market Cap | 27.54M |
| Price to Earnings Ratio | -7.23 |
| Price to Sales Ratio | 38.46 |
| Price to Cash Ratio | 1.25k |
| Price to Book Ratio | -10.31 |
| Dividend Yield | - |
| Shares Outstanding | 110.16M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 1.68k |
| 52 Week Change | 25.00% |
| 52 Week High | 0.2932 |
| 52 Week Low | 0.0021 |
| Spread (Intraday) | 0.24 (98.29%) |
| Company Name | Rapid Dose Therapeutics Corp (PK) |
| Address |
1121 walker's line, unit 3a burlington, ontario L7N 2G4 |
| Website | https://rapid-dose.com |
| Industry | unit inv tr, closed-end mgmt (6726) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
